Achieve Life Sciences, Inc. financial data

Symbol
ACHV on Nasdaq
Location
22722 29 Th Dr. Se, Suite 100, Seattle, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 524 % +68.2%
Debt-to-equity 66.2 % +0.18%
Return On Equity -197 % -81.6%
Return On Assets -118 % -81.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.2M shares +54.8%
Common Stock, Shares, Outstanding 52.8M shares +53.6%
Entity Public Float 144M USD +58.8%
Common Stock, Value, Issued 121K USD +17.5%
Weighted Average Number of Shares Outstanding, Basic 51M shares +48.5%
Weighted Average Number of Shares Outstanding, Diluted 51M shares +48.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 26.4M USD +49.8%
General and Administrative Expense 25.9M USD +90.2%
Costs and Expenses 52.3M USD +67.4%
Nonoperating Income (Expense) -7K USD +99.6%
Net Income (Loss) Attributable to Parent -52.3M USD -58.9%
Earnings Per Share, Basic -1 USD/shares -26.4%
Earnings Per Share, Diluted -1 USD/shares -26.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.9M USD +235%
Marketable Securities, Current 16.2M USD
Cash, Cash Equivalents, and Short-term Investments 48.1M USD +12.1%
Assets, Current 50.1M USD +9.94%
Property, Plant and Equipment, Net 8K USD -38.5%
Operating Lease, Right-of-Use Asset 79K USD +295%
Goodwill 1.03M USD 0%
Assets 52M USD +8.6%
Accounts Payable, Current 1.94M USD +92.2%
Employee-related Liabilities, Current 2.43M USD +3.76%
Liabilities, Current 9.73M USD +44.9%
Operating Lease, Liability, Noncurrent 21K USD
Liabilities 18.4M USD +11.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9K USD -88%
Retained Earnings (Accumulated Deficit) -246M USD -27.1%
Stockholders' Equity Attributable to Parent 33.6M USD +7.13%
Liabilities and Equity 52M USD +8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.1M USD -110%
Net Cash Provided by (Used in) Financing Activities 56.1M USD +119283%
Net Cash Provided by (Used in) Investing Activities 11.4M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 52.8M shares +53.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 263K USD -99.5%
Deferred Tax Assets, Valuation Allowance 81.8M USD +11.7%
Deferred Tax Assets, Gross 82.2M USD +11.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.4M USD -16.1%
Property, Plant and Equipment, Gross 256K USD 0%
Operating Lease, Liability, Current 59K USD +168%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 54.6M USD +11.6%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 761K USD 0%
Operating Lease, Payments 52K USD -14.8%
Amortization of Intangible Assets 200K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 330K USD -4.62%
Interest Expense 2.77M USD +6.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%